Our extended-release patent MX/a/2022/012679 — A new horizon in skin science and advanced medicine.

RŌGMA Biotechnologies, under the authorship of Rogelio Martínez Escareño , presents a pioneering innovation that marks a before and after in biotechnology applied to medicine, cosmetics, dermatology and cancer therapies .

The patent, titled “Nanostructured Lipid Formulation and Unique Fragmented Hyaluronic Acid Complex,” represents an intelligent, controlled-release system that increases the skin absorption of active ingredients by up to 90% , thanks to its biomimetic nanoencapsulated structure. This technology allows the compounds to act in a prolonged, precise, and biocompatible manner, achieving visible and clinically significant results without causing irritation or toxicity.

More than a formulation, it is a gateway to the future of regenerative medicine , where science and nature converge to optimize skin health and beauty, and enhance therapeutic efficacy in complex treatments, including cancer.

At RŌGMA, we believe that innovation not only transforms science, but also people's lives. This patent reflects our mission: to create biological technology that regenerates, protects, and enhances human potential.